Nanomedicines for kidney diseases.

Nanomedicines for kidney diseases.
复制标题

DOI:
10.1016/j.kint.2016.03.041
复制
发表时间:
2016-10
影响因子:
19.6
通讯作者:
Heller, Daniel A.
Heller, Daniel A.
中科院分区:
医学1区
文献类型:
--
作者:
Williams, Ryan M.;Jaimes, Edgar A.;Heller, Daniel A.

文献摘要

参考文献

被引文献

相似文献

Nanomedicines have been the subject of great interest for the treatment, diagnosis, and research of disease; however few specifically address kidney disorders. Nanotechnology can confer significant benefit to medicine, such as the targeted delivery of drugs to specific tissues. Nanomedicines in the clinic have increased drug solubility, reduced off-target side effects, and provided novel diagnostic tools. There is an increasing cohort of nanomaterials which may have implications for kidney disease. Here, we review nanomaterial properties that are potentially applicable to kidney research and therapy, and we highlight clinical areas of need which may benefit from kidney nanomedicines.
DOI: 10.1002/wnan.1242
发表时间: 2014-01
影响因子: 8.6
作者:
Devulapally, Rammohan;Paulmurugan, Ramasamy
通讯作者: Paulmurugan, Ramasamy
一种吸收孔形成毒素的仿生纳米质体。
DOI: 10.1038/nnano.2013.54
发表时间: 2013-05
影响因子: 38.3
作者:
通讯作者: --
DOI: 10.1073/pnas.1103573108
发表时间: 2011-04-19
影响因子: 11.1
作者:
Choi, Chung Hang J.;Zuckerman, Jonathan E.;Davis, Mark E.
通讯作者: Davis, Mark E.
DOI: 10.1124/mol.107.034140
发表时间: 2007-07-01
影响因子: 3.6
作者:
Asgeirdottir, Sigridur A.;Kamps, Jan A. A. M.;Molema, Grietje
通讯作者: Molema, Grietje
DOI: 10.1016/j.ejpb.2007.03.010
发表时间: 2007-09-01
影响因子: 4.9
作者:
Ankola, D. D.;Viswanad, B.;Kumar, M. N. V. Ravi
通讯作者: Kumar, M. N. V. Ravi